AF
ALBO

Amalgamated Financial’s Albireo Pharma Inc ALBO Stock Holding History

Amalgamated Financial’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$78K Buy
+2,602
New +$76.2K ﹤0.01% 2247

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Amalgamated Financial's ALBO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Albireo Pharma Inc (ALBO) in Q1 2022: 2,602 shares worth $78K. The stake represents ﹤0.01% of the portfolio and ranks #2247 among its holdings.

109 funds tracked by Wall St. Rank hold ALBO as of Q1 2022.

  • Amalgamated Financial held 2,602 shares of Albireo Pharma Inc worth $78K as of Q1 2022.
  • Albireo Pharma Inc was a new Amalgamated Financial position in Q1 2022.
  • Albireo Pharma Inc made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2247 holding.
  • 109 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.